Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FBIOX vs. BIB: which is better?

Bottom line

FBIOX vs BIB: the short answer

FBIOX (Biotechnology Portfolio) and BIB (ProShares Ultra Nasdaq Biotechnology) are quite different portfolios: only about 30% of their top holdings (by weight) are shared.

FBIOX is cheaper at 0.62% vs 0.95% — a difference of $33 a year per $10,000 invested.

Over five years, FBIOX returned +3.5% a year vs −1.0% for BIB (reporting dates differ).

Updated Nov 19, 2026

FBIOX vs BIB side by side

FBIOXBIB
TypeMutual fundETF
Fund familyFidelityProShares
CategoryTechnology SectorTechnology Sector
Expense ratio0.62%0.95%
Annual cost per $10k$62$95
10-yr cost on $10k (prospectus)$774$1,401
Max front load—None
12b-1 fee0%—
1-yr return+36.4%+59.3%
5-yr return (annualized)+3.5%−1.0%
10-yr return (annualized)+6.9%+1.4%
Best quarter+33.6%+56.2%
Worst quarter−28.4%−42.7%
Net assets (fund)$5.3B$73.7M
Number of holdings215267
Portfolio turnover45%29%
Returns as ofApr 30, 2026Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFBIOXBIBDifference
2025+36.4%+59.3%−23.0%
2024+7.3%−10.0%+17.3%
2023+10.1%−1.3%+11.4%
2022−15.9%−28.6%+12.8%
2021−12.4%−5.9%−6.5%
2020+38.3%+39.7%−1.4%
2019+36.0%+45.5%−9.6%
2018−10.7%−24.4%+13.6%
2017+27.9%+40.8%−12.9%
2016−23.7%−44.2%+20.5%

Source: Fund prospectus bar charts

Holdings overlap

9 of FBIOX's top 25 holdings also appear in BIB's top 25.

Shared top holdings
HoldingFBIOXBIB
Amgen Inc6.53%4.48%
Gilead Sciences Inc4.82%4.66%
Alnylam Pharmaceuticals Inc2.93%2.01%
Insmed Inc2.25%1.16%
Argenx Se2.25%1.19%
Revolution Medicines Inc2.02%1.57%
Moderna Inc1.28%0.94%
Biogen Inc1.26%1.44%
Roivant Sciences Ltd1.13%1.08%

Source: SEC Form N-PORT

FBIOX top 10

  1. Krystal Biotech Inc — 10.58%
  2. Abbvie Inc — 9.22%
  3. Amgen Inc — 6.53%
  4. Gilead Sciences Inc — 4.82%
  5. Fidelity Revere Street Trust — 3.35%
  6. Alnylam Pharmaceuticals Inc — 2.93%
  7. Praxis Precision Medicines Inc. — 2.47%
  8. Insmed Inc — 2.25%
  9. Argenx Se — 2.25%
  10. Ascendis Pharma A/s — 2.04%

BIB top 10

  1. N/a — 7.35%
  2. ProShares GENIUS Money Market ETF — 6.80%
  3. Gilead Sciences, Inc. — 4.66%
  4. Vertex Pharmaceuticals, Inc. — 4.65%
  5. Amgen, Inc. — 4.48%
  6. N/a — 3.94%
  7. N/a — 3.26%
  8. Regeneron Pharmaceuticals, Inc. — 3.21%
  9. N/a — 2.62%
  10. Alnylam Pharmaceuticals, Inc. — 2.01%

FAQ

What is the difference between FBIOX and BIB?
FBIOX (Biotechnology Portfolio) and BIB (ProShares Ultra Nasdaq Biotechnology) are quite different portfolios: only about 30% of their top holdings (by weight) are shared. FBIOX is cheaper at 0.62% vs 0.95% — a difference of $33 a year per $10,000 invested.
Which is cheaper, FBIOX or BIB?
FBIOX has the lower expense ratio (0.62%).
Should I own both FBIOX and BIB?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.